From: Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look
Study Title | ClinicalTrials.gov ID | Status | Study Type | Phase |
---|---|---|---|---|
KrasG12D siRNA-loaded MSC Exos (iExos) for treating patients with pancreatic cancer with KrasG12D mutation | NCT03608631 | Active, not recruiting | Interventional | I |
CDK-002-loaded Exos (exoSTING) in subjects with Advanced and metastatic neck squamous cell cancer, triple negative breast cancer, anaplastic thyroid carcinoma, and cutaneous squamous cell carcinoma | NCT04592484 | Completed | Interventional | I and II |